Published 1 day ago • loading... • Updated 8 hours ago

Eli Lilly plans at least $27 billion in new U.S. manufacturing investments

Eli Lilly will invest $27 billion to build four new manufacturing plants in the United States to boost domestic production as President Donald Trump warns of new tariffs on pharmaceuticals.
Three plants will produce active pharmaceutical ingredients, while one will make injectable products, according to Eli Lilly.
The investments are expected to create 13,000 jobs and reflect an effort to increase manufacturing capacity for drugs like Zepbound and Mounjaro, which have faced shortages.
David Ricks, Eli Lilly's CEO, stated that the new facilities will support future medicines and emphasized the risks of relying on offshored production for vital technologies.

Insights by Ground AI

Does this summary seem wrong?

36 Articles

All

Left

Center

Right

The Daily Caller

Eli Lilly Announces Plan To Invest $27 Billion In America Amid Trump Tariff Threats

Eli Lilly announced that it plans to increase its manufacturing investment this year as President Trump threatens to place tariffs on pharmaceutical imports.

19 hours ago·Washington, United States

Read Full Article

Al Jazeera

Eli Lilly plans $27bn in new plants as Trump threatens pharma tariffs

The new plants will be built in the US over the next five years and create 3,000 jobs for skilled workers.

19 hours ago·Qatar

Read Full Article

New York Post

Eli Lilly plans to invest $27B to build four new US plants as tariffs loom

Eli Lilly has unveiled plans to invest $27 billion in the construction of four new manufacturing plants in the United States.

19 hours ago·New York, United States

Read Full Article

Investing.com

Eli Lilly to invest another $27 billion in U.S. manufacturing By Investing.com

Eli Lilly to invest another $27 billion in U.S. manufacturing

22 hours ago

Read Full Article

Wall Street Journal

Eli Lilly Plans to Spend $27 Billion on New U.S. Plants

The pharmaceutical company expects the expansion will create thousands of jobs

22 hours ago·New York, United States

Read Full Article

Reuters

Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs

Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with the threat of drug import duties from the Trump administration.

22 hours ago·United Kingdom

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year